Literature DB >> 6757139

Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.

R P Bos, A O Leenaars, J L Theuws, P T Henderson.   

Abstract

Mutagenicity towards Salmonella typhimurium TA 100 of urine from smoking nurses, who were occupationally involved in the treatment of patients with cytostatic drugs, was significantly increased in comparison with that of smoking control subjects. Mutagenicity towards Salmonella typhimurium TA 100 was not increased in exposed non-smokers when compared to control non-smokers. In smoking subjects urinary mutagenicity appeared increased towards Salmonella typhimurium TA 1538 in the presence of S-9 mix. Rats pretreated with Aroclor 1254 showed higher mutagenicity in their urine than untreated rats after cyclophosphamide administration. Therefore, the synergistic effect of smoking might be due in part to induction of enzymes involved in the mutagenic activation of cytostatic drugs. Further, the animal experiments showed that cyclophosphamide (the most frequently used mutagenic cytostatic drug) can be absorbed after oral or percutaneous administration. Therefore, it is not excluded that differences in working hygiene between smokers and non-smokers also play a role.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757139     DOI: 10.1007/bf00377832

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  20 in total

1.  Mutagenicity in urine of nurses handling cytostatic drugs.

Authors:  K Falck; P Gröhn; M Sorsa; H Vainio; E Heinonen; L R Holsti
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

2.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

3.  Mutagenicity in urine of workers in rubber industry.

Authors:  K Falck; M Sorsa; H Vainio; I Kilpikari
Journal:  Mutat Res       Date:  1980-09       Impact factor: 2.433

4.  Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat.

Authors:  W R Leopold; E C Miller; J A Miller
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

5.  Chromosome analyses of nurses handling cytostatic agents.

Authors:  H Waksvik; O Klepp; A Brøgger
Journal:  Cancer Treat Rep       Date:  1981 Jul-Aug

6.  Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs.

Authors:  H Norppa; M Sorsa; H Vainio; P Gröhn; E Heinonen; L Holsti; E Nordman
Journal:  Scand J Work Environ Health       Date:  1980-12       Impact factor: 5.024

7.  Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.

Authors:  Y Seino; M Nagao; T Yahagi; A Hoshi; T Kawachi; T Sugimura
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

8.  Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light.

Authors:  L A Wheeler; M D Saperstein; N J Lowe
Journal:  J Invest Dermatol       Date:  1981-08       Impact factor: 8.551

Review 9.  The carcinogenicity of anticancer drugs: a hazard in man.

Authors:  C C Harris
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

Review 10.  Influence of cigarette smoking on drug metabolism in man.

Authors:  W J Jusko
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

View more
  21 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

2.  Effectiveness of cleaning of workplace cytotoxic surface.

Authors:  Laetitia Minh Mai Lê; Pierre Alain Jolivot; Hassane Sadou Yaye; André Rieutord; Agnès Bellanger; Dominique Pradeau; Séverine Barbault-Foucher; Eric Caudron
Journal:  Int Arch Occup Environ Health       Date:  2012-04-12       Impact factor: 3.015

Review 3.  The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 4.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

5.  Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.

Authors:  E P Guinée; G H Beuman; G Hageman; I J Welle; J C Kleinjans
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

6.  Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs.

Authors:  Laurent Benoit; Nicolas Cheynel; Pablo Ortega-Deballon; Giovanni Di Giacomo; Bruno Chauffert; Patrick Rat
Journal:  Ann Surg Oncol       Date:  2007-10-10       Impact factor: 5.344

7.  Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.

Authors:  C T Evelo; R P Bos; J G Peters; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

8.  Urinary excretion of mutagens, thioethers and D-glucaric acid in workers exposed to bitumen fumes.

Authors:  R Pasquini; S Monarca; G Scassellati Sforzolini; A Savino; F A Bauleo; G Angeli
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

9.  Mutagenicity of urine from young male smokers and nonsmokers.

Authors:  H Kawano; T Inamasu; M Ishizawa; N Ishinishi; J Kumazawa
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

10.  Determinants of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurement of 1-hydroxypyrene in urine: a cross-sectional study in workers of coke and graphite-electrode-producing plants.

Authors:  M Ferreira; J P Buchet; J B Burrion; J Moro; L Cupers; J P Delavignette; J Jacques; R Lauwerys
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.